Copyright
©The Author(s) 2023.
World J Gastroenterol. Aug 28, 2023; 29(32): 4883-4899
Published online Aug 28, 2023. doi: 10.3748/wjg.v29.i32.4883
Published online Aug 28, 2023. doi: 10.3748/wjg.v29.i32.4883
Clinical characteristics (n = 2203) | Value1 |
Age (yr) | 64.7 ± 12.2 |
Sex | |
Male | 1264 (57.4) |
Female | 939 (42.6) |
Body mass index (kg/m2) | 23.9 ± 3.3 |
ASA score | |
1 | 575 (26.1) |
2 | 1412 (64.1) |
3 | 211 (9.6) |
4 | 5 (0.2) |
Cancer location | |
Cecum | 46 (2.1) |
Ascending colon | 386 (17.5) |
Hepatic flexure | 88 (4.0) |
Transverse colon | 115 (5.2) |
Splenic flexure | 18 (0.8) |
Descending colon | 79 (3.6) |
Sigmoid colon | 771 (35.0) |
Rectum | 700 (31.7) |
Preoperative CEA (ng/mL) | 7.7 ± 42.3 |
Diverting stoma | |
Ileostomy | 435 (19.7) |
Colostomy | 62 (2.8) |
T stage | |
0 | 18 (0.8) |
1 | 275 (12.5) |
2 | 383 (17.4) |
3 | 1282 (58.2) |
4 | 245 (11.1) |
N stage | |
0 | 1286 (58.4) |
1 | 639 (29.0) |
2 | 278 (12.6) |
Tumor size (cm) | 4.4 ± 2.4 |
Lymphatic invasion | 597 (27.1) |
Vascular invasion | 469 (21.3) |
Perineural invasion | 934 (42.4) |
Harvested lymph nodes | 45.3 ± 21.2 |
Metastatic lymph nodes | 1.4 ± 2.9 |
Adjuvant/Neoadjuvant therapy | |
Colon | |
Adjuvant therapy-stage II | 274 (51.4) |
Adjuvant therapy-stage III | 575 (90.0) |
Rectum | |
Neoadjuvant therapy | 200 (28.6) |
Operative first-Adjuvant therapy | 264 (52.8) |
- Citation: Ahn HM, Kim DW, Oh HJ, Kim HK, Lee HS, Lee TG, Shin HR, Yang IJ, Lee J, Suh JW, Oh HK, Kang SB. Different oncological features of colorectal cancer codon-specific KRAS mutations: Not codon 13 but codon 12 have prognostic value. World J Gastroenterol 2023; 29(32): 4883-4899
- URL: https://www.wjgnet.com/1007-9327/full/v29/i32/4883.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i32.4883